Financial Performance - For the three months ended June 30, 2021, the group's revenue was approximately HKD 52.5 million, compared to HKD 18.8 million for the same period in 2020, representing an increase of 179%[17]. - The group generated a net profit of approximately HKD 5.1 million for the three months ended June 30, 2021, compared to a net loss of HKD 4.8 million for the same period in 2020[17]. - The total comprehensive income for the period was HKD 5.1 million, compared to a total comprehensive loss of HKD 4.8 million in the previous year[19]. - Basic earnings per share for the three months ended June 30, 2021, were HKD 0.64, compared to a loss per share of HKD 0.60 for the same period in 2020[19]. - The group reported a profit before tax of HKD 5,127,000 for the three months ended June 30, 2021, compared to a loss of HKD 4,789,000 in the same period of 2020[40]. Revenue Breakdown - Revenue from treatment services reached HKD 51,389,000 for the three months ended June 30, 2021, compared to HKD 18,030,000 in the same period of 2020, representing an increase of 185.5%[32]. - Total revenue for the group was HKD 52,459,000 for the three months ended June 30, 2021, compared to HKD 18,817,000 in the same period of 2020, marking a growth of 178.5%[32]. - For the three months ended June 30, 2021, the company's revenue was approximately HKD 52.5 million, an increase of about HKD 33.7 million or 179.3% compared to the same period in 2020[47]. Cost and Expenses - Employee costs for the three months ended June 30, 2021, were HKD 16.7 million, up from HKD 8.3 million in the same period in 2020, reflecting a 100% increase[19]. - The total employee costs amounted to HKD 16,651,000 for the three months ended June 30, 2021, up from HKD 8,339,000 in the same period of 2020, reflecting a 99.5% increase[35]. - The cost of inventory and consumables for the three months ended June 30, 2021, was approximately HKD 7.8 million, up from HKD 2.8 million in the same period of 2020, consistent with revenue growth[51]. - Depreciation expenses for property, plant, and equipment rose to approximately HKD 3.9 million from HKD 2.9 million, attributed to new property and equipment acquisitions[56]. - The financing costs for the three months ended June 30, 2021, were HKD 1.3 million, compared to HKD 0.5 million in the same period in 2020, indicating a 174% increase[19]. - Deferred tax expenses were HKD 468,000 for the three months ended June 30, 2021, compared to HKD 247,000 in the same period of 2020, an increase of 89.5%[37]. Dividend Policy - The board of directors did not recommend the distribution of dividends for the three months ended June 30, 2021, consistent with no dividends declared in 2020[17]. - The group did not recommend any dividend for the three months ended June 30, 2021, consistent with the previous year[39]. - The company did not recommend any dividend distribution for the three months ended June 30, 2021, consistent with the previous year[61]. Strategic Plans - The group plans to expand its market presence and enhance product offerings in the upcoming quarters[25]. - The company is focused on developing new technologies and products to drive future growth and profitability[25]. - The company plans to expand its operations by opening new centers to capture growing customer demand and enhance market penetration in Hong Kong[46]. - The company aims to maximize shareholder value by leveraging its strong customer base and reputation to drive steady business growth[49]. - The company has expanded its service offerings to include training courses recognized under the Hong Kong Qualifications Framework for laser and light beauty treatments[46]. Shareholder Information - As of June 30, 2021, Mr. Ye and Ms. Fu each hold 600,000,000 shares in Equal Joy, representing a 75% equity stake[69]. - Equal Joy is jointly owned by Mr. Ye and Ms. Fu, each holding a 50% beneficial interest in the total issued shares[70]. - The weighted average number of ordinary shares issued was 800,000 for both the three months ended June 30, 2021, and 2020, indicating no change in share structure[42]. - No other directors or key executives have disclosed any interests or short positions in the company's shares or related securities as of June 30, 2021[72]. - The company has adopted a share option scheme to attract and reward qualified individuals, effective for ten years from September 21, 2018[77]. - No share options have been granted, exercised, or cancelled under the share option scheme since its adoption[77]. - As of June 30, 2021, the company has no unexercised share options, warrants, derivatives, or convertible securities[77]. - There are no arrangements for directors to acquire shares or debt securities of the company or any other corporation[79]. - No directors or their associates are engaged in any business that competes directly or indirectly with the group[80]. - The board of directors includes Mr. Ye and Ms. Fu as executive directors, with independent non-executive directors also serving[81]. Other Income - The group reported other income of HKD 147,000 for the three months ended June 30, 2021, significantly down from HKD 4,039,000 in the same period of 2020[35]. - Other income decreased to approximately HKD 0.1 million from HKD 4.0 million, primarily due to the absence of government subsidies during the period[53]. COVID-19 Impact - The group continues to monitor the impact of COVID-19 on its financial performance and operations, indicating ongoing strategic adjustments[44]. - The group applied new Hong Kong Financial Reporting Standards effective from April 1, 2021, with no significant impact on the financial statements for the current and prior periods[30].
亮晴控股(08603) - 2022 Q1 - 季度财报